Nonsteroidal anti-inflammatory drug (NSAID) use and sarcopenia in older people: Results from the ilsirente study

Journal of the American Medical Directors Association

Volumn 14, Issue 8, 2013, Pages 626.e9-626.e13

  Landi, Francesco ^a   Marzetti, Emanuele ^a   Liperoti, Rosa ^a   Pahor, Marco ^b   Russo, Andrea ^a   Martone, Anna Maria ^a   Colloca, Giuseppe ^a   Capoluongo, Ettore ^a   Bernabei, Roberto ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

IlSIRENTE study; NSAID; Sarcopenia

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; MUSCLE STRENGTH; OSTEOARTHRITIS; PHYSICAL PERFORMANCE; PROTEIN BLOOD LEVEL; SARCOPENIA;

EID: 84881232588     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2013.04.012     Document Type: Article

References (35)

1. Beyer I., Mets T., Bautmans I. Chronic low-grade inflammation and age-related sarcopenia. Curr Opin Clin Nutr Metab Care 2012, 15:12-22.
2. Fielding R.A., Vellas B., Evans W.J., et al. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. JAm Med Dir Assoc 2011, 12:249-256.
3. Cruz-Jentoft A.J., Landi F., Topinková E., Michel J.P. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care 2010, 13:1-7.
4. Beyer I., Njemini R., Bautmans I., et al. Inflammation-related muscle weakness and fatigue in geriatric patients. Exp Gerontol 2012, 47:52-59.
5. Schaap L.A., Pluijm S.M., Deeg D.J., et al. Higher inflammatory marker levels in older persons: Associations with 5-year change in muscle mass and muscle strength. JGerontol A Biol Sci Med Sci 2009, 64:1183-1189. Health ABC Study.
6. Powers S.K., Kavazis A.N., McClung J.M. Oxidative stress and disuse muscle atrophy. JAppl Physiol 2007, 102:2389-2397.
7. Saini A., Faulkner S., Al-Shanti N., Stewart C. Powerful signals for weak muscles. Ageing Res Rev 2009, 8:251-267.
8. Landi F., Liperoti R., Fusco D., et al. Prevalence and risk factors of sarcopenia among nursing home older residents. JGerontol A Biol Sci Med Sci 2012, 67:48-55.
9. Eid A.A., Ionescu A.A., Nixon L.S., et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 164:1414-1418.
10. Fink A.M., Gonzalez R.C., Lisowski T., et al. Fatigue, inflammation, and projected mortality in heart failure. JCard Fail 2012, 18:711-716.
11. Abdelmagid S.M., Barr A.E., Rico M., et al. Performance of repetitive tasks induces decreased grip strength and increased fibrogenic proteins in skeletal muscle: Role of force and inflammation. PLoS One 2012, 7:e38359.
12. Mets T., Bautmans I., Njemini R., et al. The influence of celecoxib on muscle fatigue resistance and mobility in elderly patients with inflammation. Am J Geriatr Pharmacother 2004, 2:230-238.
13. Beyer I., Bautmans I., Njemini R., et al. Effects on muscle performance of NSAID treatment with piroxicam versus placebo in geriatric patients with acute infection-induced inflammation. A double blind randomized controlled trial. BMC Musculoskelet Disord 2011, 12:292.
14. Landi F., Russo A., Liperoti R., et al. Anorexia, physical function, and incident disability among the frail elderly population: Results from the ilSIRENTE study. JAm Med Dir Assoc 2010, 11:268-274.
15. Morris J.N., Fries B.E., Steel K., et al. Comprehensive clinical assessment in community setting: Applicability of the MDS-HC. JAm Geriatr Soc 1997, 45:1017-1024.
16. Landi F., Russo A., Danese P., et al. Anemia status, hemoglobin concentration, and mortality in nursing home older residents. JAm Med Dir Assoc 2007, 8:322-327.
17. Ferrucci L., Bandinelli S., Benvenuti E., et al. Subsystems contributing to the decline in ability to walk: Bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. JAm Geriatr Soc 2000, 48:1618-1625.
18. Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010, 39:412-423. European Working Group on Sarcopenia in Older People.
19. Antonelli Incalzi R., Landi F., Cipriani L., et al. Nutritional assessment: A primary component of multidimensional geriatric assessment in the acute care setting. JAm Geriatr Soc 1996, 44:166-174.
20. Landi F., Russo A., Liperoti R., et al. Midarm muscle circumference, physical performance and mortality: Results from the aging and longevity study in the Sirente geographic area [ilSIRENTE study]. Clin Nutr 2010, 29:441-447.
21. Kuikka L.K., Salminen S., Ouwehand A., et al. Inflammation markers and malnutrition as risk factors for infections and impaired health-related quality of life among older nursing home residents. JAm Med Dir Assoc 2009, 10:348-353.
22. Yeh S.S., Blackwood K., Schuster M.W. The cytokine basis of cachexia and its treatment: Are they ready for prime time?. JAm Med Dir Assoc 2008, 9:219-236.
23. Haren M.T., Malmstrom T.K., Miller D.K., et al. Higher C-reactive protein and soluble tumor necrosis factor receptor levels are associated with poor physical function and disability: A cross-sectional analysis of a cohort of late middle-aged African Americans. JGerontol A Biol Sci Med Sci 2010, 65:274-281.
24. Bautmans I., Onyema O., Van Puyvelde K., et al. Grip work estimation during sustained maximal contraction: Validity and relationship with physical dependency and inflammation in elderly persons. JNutr Health Aging 2011, 15:731-736.
25. Tiainen K., Hurme M., Hervonen A., et al. Inflammatory markers and physical performance among nonagenarians. JGerontol 2010, 65:658-663.
26. Sullivan D.H., Roberson P.K., Johnson L.E., et al. Association between inflammation-associated cytokines, serum albumins, and mortality in the elderly. JAm Med Dir Assoc 2007, 8:458-463.
27. Aleman H., Esparza J., Ramirez F.A., et al. Longitudinal evidence on the association between interleukin-6 and C-reactive protein with the loss of total appendicular skeletal muscle in free-living older men and women. Age Ageing 2011, 40:469-474.
28. Roubenoff R., Roubenoff R.A., Cannon J.G., et al. Rheumatoid cachexia: Cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. JClin Invest 1994, 93:2379-2386.
29. Cesari M., Vellas B. Sarcopenia: A novel clinical condition or still a matter for research?. JAm Med Dir Assoc 2012, 13:766-767.
30. Visser M., Pahor M., Taaffe D.R., et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. JGerontol A Biol Sci Med Sci 2002, 57:M326-M332.
31. Lee S.W., Dai G., Hu Z., et al. Regulation of muscle protein degradation: Coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase. JAm Soc Nephrol 2004, 15:1537-1545.
32. Roubenoff R. Catabolism of aging: Is it an inflammatory process?. Curr Opin ClinNutr Metab Care 2003, 6:295-299.
33. Landi F., Marzetti E., Bernabei R. Protein: What kind, how much, when?. JAm Med Dir Assoc 2013, 14:66-67.
34. Landi F., Laviano A., Cruz-Jentoft A.J. The anorexia of aging: Is it a geriatric syndrome?. JAm Med Dir Assoc 2010, 11:153-156.
35. Landi F., Liperoti R., Fusco D., et al. Sarcopenia and mortality among older nursing home residents. JAm Med Dir Assoc 2012, 13:121-126.